Eglonil. Tohutohu mō te whakamahi, inenga me contraindications

Te faaineineraa taonga kaha "Eglonil" he sulpiride, benzamide neuroleptic he mahi neuroleptic āhua. Tenei kaihoko ho'oraa kua runga i te stimulant tinana, pānga raau.

"Eglonil" (ngā kaiwhakamahi) i roto i te pokapū pūnaha ārai receptors dopaminergic io nei e kei roto i te pūnaha limbic. Hei whakatutuki i te horopeta tino arotau o te pānga sulpiride ähotea he nui atu i te 600 mg. whakaritea horopeta ki 600 mg te i roto i te tikanga ki te whiwhi i te whakaongaonga, mahi raau.

I roto i te pota iti whakahaere ato'a sulpiride i te maimoatanga o psychosomatic mate pūāhua. tohu whai hua i roto i te whakaiti i tohu kino o te whewhe pekitīlia "Eglonil" ako. Tūroro ki syndrome whēkau pukukino e tango sulpiride, he hekenga i roto i te kaha o te mamae puku.

I roto i te toketaá iti Sulpiride (50-300 mg) faaore whanoke.

"Eglonil": tohutohu mō te whakamahi

ngā te raau i te tahi atu raau taero psychotropic rongoā whakamahia rite monotherapy ranei:

• i roto i te tuakoi whakapeka, me te ma'i;
• āhua mate kuawa whakapeka;
• korekore o ngā takenga;
• ki pau te, manukanuka, whakakitea i roto i te tūroro pakeke;
• ki nui disorders whanonga i roto i ngā tamariki te hunga i tae ono nga tau, tae atu ki te tūāwhiotanga (50 mg).

"Eglonil": dosing ā-

otinga

Hei hopu āhotea whakapeka (rite te pai rite i roto i te puka ma'i) e whakaritea / m sulpiride i werohia i te inenga o i 400 mg ki 800 mg. Kei te hangaia Treatment hoki ki runga ki te 14 nga ra.

"Eglonil" pire

I roto i te wā o te wairua tuakoi whakapeka, me te ma'i, āhotea whakaeke kuawa, whiriwhiri te korekore tākuta he horopeta rā o i 200 mg ki 1000 mg wehea ki 2-3 werohanga.

"Eglonil" capsule

I roto i te maimoatanga o te manukanuka neurosis me mana'o i roto i ngā pakeke i whakaritea tarukino i roto i te horopeta rā o i 50 mg ki 150 mg ki runga ki te 4 wiki.

I roto i te kino disorders whanonga i roto i ngā tamariki, te tūāwhiotanga tātai horopeta ia i roto i te nui o 5 mg ia 1 kg taimaha tinana ki te 10 mg ia 1 kg.

No te tūroro e kua tae koroheketanga, te horopeta o sulpiride ko ¼ o te timatanga o te maimoatanga, ranei ½ o te horopeta noa taunakitia.

I roto i te tātaritanga e pā ana, kore tino mate täkihi, te whakaiti i te rata i te horopeta e faarahi te wā i waenganui i whakahaere.

"Eglonil": pānga taha

maumaui taea i roto i te pūnaha endocrine: te whanaketanga o te hyperprolactinemia reversible, e puta galactorrhea, amenorrhea, tätou paheketanga, rawa uaua kitea tohu o gynecomastia, paruparu me te frigidity. I te tahi taime amuamu tūroro o sweating nui, te takanga o te taimaha nui.

faarahi te reira i te mahi o te whākōkī ate.

pahono CNS ki te wā roa-whakamahi "eglonil": sleepiness, whanoke, faaati, dyskinesia wawe.

I roto i te mahi hauora, i reira he take onge o dyskinesia tardive, faaite nei i roto i nekehanga tumu o te arero, mata, i muri i te whakamahi roa, "Ekerona".

A, no te sulpiride whakakore tūāhuruiti fariiraa no te tohu kirika te tūponotanga o te tātaritanga "syndrome mārere neuroleptic" (CSN).

pūnaha Cardiovascular ētahi wā tauhohe ki te fariiraa "eglonil" tachycardia, pēhanga toto tiketike, rawa uaua - te whanaketanga o te hypotension orthostatic, QT roa.

mate pāwera he ponana kiri.

Eglonil: ako (contraindications)

Sulpiride prolaktinzavisimymi contraindicated i roto i te tūroro ki te pukupuku, hyperprolactinemia, haurangi, i roto i te wera o te riri, āhotea härukiruki, ki pheochromocytoma. Kaua e tangohia "Eglonil" te u,.

Rāhuitia e werohia rō-uaua o te sulpiride tamariki i raro i te 18 tau o te tau, kia rite ki te pai kia rite ki te fariiraa o capsules tamariki i raro i 6 tau.

E kore e manakohia ana ngā ki agonists sulpiride o receptors dopaminergic me sultopride.

Rongoā contraindicated ki hypersensitivity ki tetahi o nga kai.